Aceso Life Science Group | Sustainability Performance
Engages in biomedical research and development, with operations covering diagnostics, treatments, and healthcare delivery models. Participates in early-stage innovation, clinical trials, and product commercialization in cooperation with research institutions and healthcare providers.
1985
Hong Kong
51 - 200 employees
Real Estate
$25M - 100M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#9103
Overall#136
in Hong Kong#415
in Real EstateSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Revenue
Controversy level
Powered by illuminem
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$195.0MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.3
20230.2
20240.2
2025Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
43%
Independent Directors
3 out of 7 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
